Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

NCT07732712 is registered in ClinicalTrials.gov with The Affiliated People's Hospital of Ningbo University as lead sponsor.

NCT NCT07732712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07732712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells
Lead sponsor
The Affiliated People's Hospital of Ningbo University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
December 31, 2030
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma